iBio
IBIO
#10085
Rank
HK$0.54 B
Marketcap
HK$10.98
Share price
-0.71%
Change (1 day)
137.17%
Change (1 year)

iBio (IBIO) - Total assets

Total assets on the balance sheet as of March 2026 : HK$0.67 Billion

According to iBio's latest financial reports the company's total assets are HK$0.67 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

iBio - Total assets on balance sheet (from 2008 to 2026)

Total assets by year

Year Total assets Change
2025-06-30HK$0.18 B-18.89%
2024-06-30HK$0.22 B-30.51%
2023-06-30HK$0.32 B-58.61%
2022-06-30HK$0.78 B-31.64%
2021-06-30HK$1.14 B56.31%
2020-06-30HK$0.73 B205.53%
2019-06-30HK$0.23 B-29.34%
2018-06-30HK$0.33 B20.28%
2017-06-30HK$0.28 B-29.79%
2016-06-30HK$0.40 B313.46%
2015-06-30HK$96.84 M92.42%
2014-06-30HK$50.32 M-30.63%
2013-06-30HK$72.54 M-4.23%
2012-06-30HK$75.75 M32.69%
2011-06-30HK$57.08 M48.67%
2010-06-30HK$38.39 M0.5%
2009-06-30HK$38.2 M38.06%
2008-06-30HK$27.67 M-6.03%
2007-06-30HK$29.45 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
HK$1.576 T 233,949.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
HK$0.30 B-54.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$5.98 B 789.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$10.35 B 1,438.32%๐Ÿ‡บ๐Ÿ‡ธ USA